OmniAb (OABI) Receivables - Other (2023 - 2026)

OmniAb (OABI) posted quarterly Receivables - Other of $3.5 million for Q1 2026, up 400.0% year-over-year from $700000.0 in Q1 2025, and up 337.5% quarter-over-quarter from $800000.0 in Q4 2025.

OmniAb (OABI) Receivables - Other (2023 - 2026) Analysis & Trends

OmniAb (OABI) has reported Receivables - Other for 4 consecutive years, with $3.5 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Receivables - Other rose 400.0% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $3.5 million (up 400.0% YoY), while the FY2025 annual figure was $800000.0, down 69.23% from the prior year.
  • Receivables - Other rose to $3.5 million in Q1 2026 per OABI's latest filing, from $800000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $3.5 million in Q1 2026 and bottomed at $300000.0 in Q3 2025.
  • Historically, Receivables - Other has averaged $1.3 million across 4 years, with a median of $800000.0 in 2023.
  • Annual changes were most pronounced in 2025 — Receivables - Other sank 69.23% — and 2026, when it surged 400.0%.
  • OmniAb's Receivables - Other stood at $800000.0 in 2023, then jumped by 225.0% to $2.6 million in 2024, then tumbled by 69.23% to $800000.0 in 2025, then jumped by 337.5% to $3.5 million in 2026.
  • Business Quant data shows OABI's Receivables - Other at $3.5 million in Q1 2026, $800000.0 in Q4 2025, and $300000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 OmniAb 491.42 Mn 439.42 Mn 12.81 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 900,000.00
Jun 30, 2026 900,000.00
Mar 31, 2026 3.50 Mn
Mar 31, 2026 3.50 Mn
Dec 31, 2025 800,000.00
Dec 31, 2025 800,000.00
Sep 30, 2025 300,000.00
Sep 30, 2025 300,000.00
Jun 30, 2025 400,000.00
Jun 30, 2025 400,000.00
Mar 31, 2025 700,000.00
Mar 31, 2025 700,000.00
Dec 31, 2024 2.60 Mn
Dec 31, 2024 2.60 Mn
Dec 31, 2023 800,000.00
Dec 31, 2023 800,000.00